Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The effects of excitatory amino acid antagonists on increased cortical acetylcholine release and behavioral hyperactivity induced by naloxone in morphine tolerant guinea pigs and mice were studied. The results show that the N-methyl-D-aspartic acid (NMDA) antagonist MK-801 (0.1-1 mg/kg, i.p.) injected 30 min before naloxone (3 mg/kg, s.c.) dose-dependently prevented the neurochemical and behavioral signs of morphine withdrawal in guinea pigs and mice. The non-selective antagonist glutamic acid diethylester only at 100 mg/kg i.p. reduced the naloxone-induced increase of cortical acetylcholine release without affecting the behavioral changes. These findings indicate that the activation of excitatory amino acid receptors, mainly the NMDA receptors, plays a relevant role in the expression of opiate abstinence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For opioids, the noncompetitive glutamate receptor antagonist MK-801 blocked the expression of withdrawal signs that were precipitated by naloxone in opioid-dependent animals (Tanganelli et al., 1991;Tokuyama et al., 1996), suggesting a hyperglutamatergic contribution to opioid withdrawal.”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Tanganelli et al., 1991
Citations
Cites
Bl�sig, J., Herz, A., Reinhold, K., & Zieglg�nsberger, S. (1973) · Psychopharmacologia · doi:10.1007/bf00428791 · Cited by 521
Ennis, M., & Aston-Jones, G. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-10-03644.1988 · Cited by 343
Nestler, E. J., & Tallman, J. F. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13123-4 · Cited by 234
Rasmussen, K., & Aghajanian, G. K. (1989) · Brain Research · doi:10.1016/0006-8993(89)91466-2 · Cited by 198
Noradrenaline inhibition of acetylcholine release from guinea-pig brain
Beani, L., Bianchi, C., Giacomelli, A., & Tamberi, F. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90327-8 · Cited by 167
Self-citationBritton, K. T., Svensson, T. H., Schwartz, J., Bloom, F. E., & Koob, G. F. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90583-6 · Cited by 80
Saelens, J. K., Granat, F. R., & Sawyer, W. K. (1971) · PubMed · Cited by 72
Jhamandas, K. H., & Sutak, M. (1974) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1974.tb09592.x · Cited by 55
Antonelli, T., Beani, L., Bianchi, C., Rando, S., Simonato, M., & Tanganelli, S. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb11191.x · Cited by 27
Self-citationJumping after naloxone precipitated withdrawal of chronic morphine in the rat.
Francis, D. L., & Schneider, C. (1971) · PubMed · Cited by 26
Cited by
Mechanisms of hyperalgesian and morphine tolerance: a current view of their possible interactions
Mao, J., Price, D. D., & Mayer, D. J. (1995) · Pain · doi:10.1016/0304-3959(95)00073-2 · Cited by 818
“As discussed above, spinal cord NMDA receptor activation (Tanganelli et al. 1991; Marek et al. 1991a,b; Trujillo and Akil 1991b; Ben Eliyahu et al. 1992), subsequent intracellular PKC translocation and activation (Mayer et al.”
BackgroundChronic ethanol consumption:from neuroadaptation to neurodegeneration
Fadda, F. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00032-x · Cited by 568
Rossetti, Z. L., Hmaidan, Y., & Gessa, G. L. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90706-a · Cited by 521
Glutamatergic substrates of drug addiction and alcoholism
Gass, J. T., & Olive, M. F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.039 · Cited by 484
“• NMDA receptors antagonists [270,305,319-329] • AMPA/KA receptor antagonists [322,330] • genetic deletion of NR2A [331] • genetic deletion of GluR1 [332] • mGluR5 antagonists [326,333,334] • stimulation of presynaptic Group II mGluRs [335-338] • administration of a glutamate release inhibitor [339] • activation of gl…”
BackgroundThe involvement of glial cells in the development of morphine tolerance
Song, P., & Zhao, Z.-Q. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(00)00226-1 · Cited by 445
Metadata
- Authors
- Tanganelli, S., Antonelli, T., Morari, M., Bianchi, C., & Beani, L.
- Affiliations
- University of Ferrara (IT)
- Corresponding author
- Tanganelli, S.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 1991-01
- Volume
- 122
- Issue
- 2
- Pages
- 270-272
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2020876837
- Cited by
- 117
- References
- 14
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 1 · 2012: 2
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- morphine withdrawal, glutamate receptor antagonists, NMDA receptor, MK-801, glutamic acid diethyl ester, naloxone, behavioral hyperactivity, glutamate receptors, morphine tolerance
- MeSH terms
- Acetylcholine, Animals, Cerebral Cortex, Drug Implants, Drug Tolerance, Glutamates, Guinea Pigs, Kinetics, Morphine, Naloxone, Parietal Lobe, Psychotropic Drugs, Substance Withdrawal Syndrome, N-Methylaspartate, Dizocilpine Maleate, Excitatory Amino Acid Antagonists, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. https://app.cochat.ai/papers/10.1016/0304-3940(91)90875-t
- The paper
- Tanganelli, S., Antonelli, T., Morari, M., Bianchi, C., & Beani, L. (1991). Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neuroscience Letters. https://doi.org/10.1016/0304-3940(91)90875-t
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.